Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-037150
Filing Date
2014-05-27
Accepted
2014-05-27 17:41:53
Documents
1
Period of Report
2014-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4226
  Complete submission text file 0001209191-14-037150.txt   5618
Mailing Address C/O VIROPHARMA INC 405 EAGLEVIEW BLVD EXTON PA 19341
Business Address
MILANO VINCENT (Reporting) CIK: 0001187159 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34186 | Film No.: 14870842

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations